Clinical Trials Sponsored by CivaTech Oncology

Total 4510 results

CivaTech Oncology

Not yet recruiting

CivaDerm(TM) Surface Therapy Pilot Study

Basal Cell Carcinoma | Squamous Cell Carcinoma of the Skin
CivaTech Oncology

Recruiting

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Lung Cancer | Lung Cancer Stage I | Lung Cancer Stage II

United States
CivaTech Oncology

Recruiting

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Pancreatic Cancer

United States
CivaTech Oncology

Completed

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

Cancer | Pancreas Cancer

United States
CivaTech Oncology

Completed

Linear Source Registry for Prostate Cancer (CaRePC)

Prostate Cancer

United States
CivaTech Oncology
TAB Clinical

Recruiting

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Sarcoma

United States
Memorial Sloan Kettering Cancer Center
CivaTech Oncology

Active, not recruiting

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Abdominal Malignancy | Pelvic Malignancy

United States
Vivatech

Completed

Investigation of Kritech Efficacy on Subjects Having Functional Discomfort Associated to Joints and Muscles Disorders (Easykrill)

Pain

France
Vivatech

Terminated

OMNIA Efficacy on Body Fat Mass Reduction (PEPOLUS)

Overweight
Ciliatech

Active, not recruiting

Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma (SAFARI 3)

Glaucoma, Open-Angle

Armenia
Ciliatech

Active, not recruiting

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2) (SAFARI 2)

Glaucoma, Open-Angle

Armenia
Ciliatech

Active, not recruiting

Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI FU)

Glaucoma, Open-Angle

Armenia
Ciliatech

Terminated

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI)

Glaucoma, Open-Angle

France
VivaTech International, Inc.

Recruiting

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip

Osteoarthritis

United States
VivaTech International, Inc.

Recruiting

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

Osteoarthritis

United States
Pierian Biosciences
DiaTech Oncology and Vanderbilt University

Completed

Use of the MiCK Assay for Apoptosis in AML

Leukemia, Myelocytic, Acute

United States
Ciliatech

Not yet recruiting

Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery (SAFARI4)

Glaucoma, Open-Angle | Glaucoma, Narrow Angle
VivaTech International, Inc.

Recruiting

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Osteoarthritis

United States
SENAI CIMATEC

Recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

SARS-CoV-2

Brazil
SENAI CIMATEC
Hospital Espanhol

Completed

Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

COVID-19 Virus Infection

Brazil
Vivatech
Centre d'Investigation Clinique de Grenoble CIC1406

Completed

Hot Flashes and Omega 3 (BOOM3)

Hot Flashes | Menopause | Fatty Acids

France
Azidus Brasil
SENAI CIMATEC

Not yet recruiting

Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine

COVID-19 | COVID-19 Vaccine
Charite University, Berlin, Germany
HeVaTech GmbH

Completed

Pulsatile Cupping in Low Back Pain (Cupping-LBP)

Chronic Low Back Pain

Germany
Charite University, Berlin, Germany
Company HeVaTech

Completed

Cupping in Osteoarthritis of the Knee

Osteoarthritis of the Knee

Germany
Hospital St. Joseph, Marseille, France
NOVATECH SA

Recruiting

Evaluation of the NOVATECH ® LUCIOLA TM EB Fiducial Marker During Radiotherapy Sessions in Lung Cancer Patients (LUCIOLA)

Lung Cancer

France
Midatech Pharma US Inc.
PharPoint Research, Inc.

Terminated

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Oral Mucositis

United States
Luca Szalontay
Midatech Pharma US Inc.

Completed

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma | Diffuse Pontine and Thalamic Gliomas

United States
Sabine Mueller, MD, PhD
Pacific Pediatric Neuro-Oncology Consortium; Midatech Pharma US Inc.

Completed

MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (PNOC015)

Diffuse Intrinsic Pontine Glioma

United States
Mural Oncology, Inc
Immune Oncology Network

Completed

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Non-cutaneous Squamous Cell Carcinoma of Head and Neck

United States
Hirschfeld Oncology

Not yet recruiting

Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer (GFLIPM)

Pancreatic Cancer

United States
Ikena Oncology

Recruiting

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors

Solid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene Fusions

United States, United Kingdom
Cardiff Oncology

Active, not recruiting

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Metastatic Colorectal Cancer | Colorectal Cancer

United States
Elevation Oncology

Active, not recruiting

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Sarcoma | Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Bile Duct Cancer | Bladder Cancer | Metastatic Solid Tumor | Gallbladder Cancer | Uterine Cancer | Locally Advanced Solid Tumor

United States, Korea, Republic of, Australia, Canada
CureLab Oncology

Active, not recruiting

Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Belarus
Strata Oncology

Enrolling by invitation

Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors (Sentinel)

Cancer

United States
Que Oncology

Completed

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Vasomotor Symptoms (VMS)
Bruckner Oncology

Completed

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

Pancreatic Cancer

United States
Radionetics Oncology

Recruiting

Phase 1 Study of 68Ga-R8760

Adrenocortical Carcinoma

United States
Elucida Oncology

Recruiting

A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Ovarian Diseases | Ovarian Neoplasms | Ovarian Cancer | Ovarian Epithelial Cancer | Fallopian Tube Cancer | Endometrial Neoplasms | Endometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Ovarian Carcinoma | Endometrial Adenocarcinoma | Peritoneal Cancer | Endometrioid Adenocarcinoma | Ovarian Adenocarcinoma | Ovarian Serous Adenocarcinoma and other conditions

United States
Strata Oncology

Recruiting

Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

Lymphoma | Cancer | Adult Solid Tumor | Multiple Myeloma

United States
Cardiff Oncology

Completed

Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation

Metastatic Colorectal Cancer | KRAS Gene Mutation

United States
Strata Oncology

Withdrawn

Strata EXPress™: A Study Using StrataEXP™ to Identify RNA-Expression Biomarkers in Advanced Cancer Patients (StrataEXPress)

Cancer

United States
Cardiff Oncology

No longer available

Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | KRAS Gene Mutation
Cardiff Oncology

Active, not recruiting

Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States
Arch Oncology

Completed

Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Elevation Oncology

Terminated

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer (SHERBOC)

Metastatic Breast Cancer

Germany, Spain, United States, Austria, Belgium, Canada
Alchemia Oncology

Unknown

Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC (FOLF(HA)iri)

Metastatic Colorectal Cancer

Australia
Ikena Oncology

Recruiting

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Colorectal Cancer | Pancreatic Cancer | Thyroid Carcinoma | Solid Tumor, Adult | Malignant Melanoma | Non-Small Cell Lung Carcinoma | BRAF Gene Mutation | Gliomas, Malignant | Ras (Kras or Nras) Gene Mutation | CRAF Gene Mutation

United States
Elevation Oncology

Recruiting

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Neoplasms | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasm | Pancreas Neoplasm | Stomach Neoplasm

United States, Japan
Cardiff Oncology

Completed

Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States

Clinical Trials Sponsored by CivaTech Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations